Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 4/20 | 0.67 |
| ▸ | F11 | P03951 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 2/20 | 0.60 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.60 |
| ▸ | TMPRSS2 | O15393 | 1/20 | 0.60 |
| ▸ | PDE5A | O76074 | 1/20 | 0.60 |
| ▸ | HMGCR | P04035 | 1/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.60 |
| ▸ | LCK | P06239 | 1/20 | 0.60 |
| ▸ | FYN | P06241 | 1/20 | 0.60 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.60 |
| ▸ | CA6 | P23280 | 1/20 | 0.60 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.60 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.60 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.60 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.60 |
| ▸ | TST | Q16762 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7642894 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL18083458 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL7144957 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL7251000 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL19479105 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL12326369 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL18068260 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL16731442 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL7642890 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 | |
| SCHEMBL17633988 | 1.00 | PTPN1 (0.67) | PTPN1F11USP2CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108435107-B | Preparation and application of DNA affinity nano-microspheres | 嘉兴杰赛生物科技有限公司 | 2020-10-23 | — | — | CN | claimed |
| US-7144453-B2 | Composition for preparing porous dielectric thin film containing saccharides porogen | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-12-05 | — | — | US | claimed |
| US-20040121139-A1 | Composition for preparing porous dielectric thin film containing saccharides porogen | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-06-24 | — | — | US | claimed |
| EP-1416501-A2 | Composition for preparing porous dielectric thin film containing saccharides porogen | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-05-06 | — | — | EP | claimed |
| US-20250333435-A1 | TIMOSAPONIN COMPOUNDS | GOLDPORP PHARMA LTD (CN) | 2025-10-30 | — | — | US | disclosed |
| US-12234258-B2 | Timosaponin compounds | GOLDPORP PHARMA LIMITED (CN) | 2025-02-25 | — | — | US | disclosed |
| US-20220340616-A1 | TIMOSAPONIN COMPOUNDS | GOLDPORP PHARMA LIMITED (HK) | 2022-10-27 | — | — | US | disclosed |
| US-11319338-B2 | Timosaponin compounds | GOLDPORP PHARMA LIMITED (HK) | 2022-05-03 | — | — | US | disclosed |
| US-20150050367-A1 | TIMOSAPONIN COMPOUNDS | GOLDPORP PHARMA LIMITED (HK) | 2015-02-19 | — | — | US | disclosed |
| WO-2013149580-A1 | TIMOSAPONIN COMPOUNDS | CHE CHIMING (CN) | 2013-10-10 | — | — | WO | disclosed |
| US-20100331269-A1 | TRITERPENES DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS OR ANTI-INFLAMMATORY AGENTS | UNIVERSITE DU QUEBEC A CHICOUTIMI (CA) | 2010-12-30 | — | — | US | disclosed |
| US-7539038-B2 | Nonvolatile nanochannel memory device using organic-inorganic complex mesoporous material | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2009-05-26 | — | — | US | disclosed |
| US-20060208248-A1 | Nonvolatile nanochannel memory device using organic-inorganic complex mesoporous material | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2006-09-21 | — | — | US | disclosed |
| US-20040121139-A1 | Composition for preparing porous dielectric thin film containing saccharides porogen | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-06-24 | — | — | US | disclosed |
| EP-1416501-A2 | Composition for preparing porous dielectric thin film containing saccharides porogen | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2004-05-06 | — | — | EP | disclosed |
| US-6632940-B1 | Glycosidic coupling between donor and acceptor in presence of Bronsted or Lewis acid to form glucopyranose-D- glucopyranose | LABORATOIRES GOEMAR (FR) | 2003-10-14 | — | — | US | disclosed |
| EP-1071692-B1 | METHOD FOR LAMINARIBIOSE SYNTHESIS | GOEMAR LAB SA (FR) | 2002-07-31 | — | — | EP | disclosed |
| EP-1071692-A1 | METHOD FOR LAMINARIBIOSE SYNTHESIS | LABORATOIRES GOEMAR (FR) | 2001-01-31 | — | — | EP | disclosed |
| WO-1999052920-A1 | METHOD FOR LAMINARIBIOSE SYNTHESIS | LABORATOIRES GOEMAR (FR) | 1999-10-21 | — | — | WO | disclosed |
| EP-0306168-A1 | Preparation of radiolabeled conjugates | IMMUNOMEDICS, INC. (US) | 1989-03-08 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12234258-B2 | Timosaponin compounds | APP, IAPP, BACE1 | PTPN1 3996/4885F11 1228/4885USP2 4673/4885 |
| US-20220340616-A1 | TIMOSAPONIN COMPOUNDS | APP, IAPP, BACE1 | PTPN1 3996/4885F11 1228/4885USP2 4673/4885 |
| US-20150050367-A1 | TIMOSAPONIN COMPOUNDS | APP, IAPP, BACE1 | PTPN1 3996/4885F11 1228/4885USP2 4673/4885 |
| US-20100331269-A1 | TRITERPENES DERIVATIVES AND USES THEREOF AS ANTITUMOR AGENTS OR ANTI-INFLAMMATORY AGENTS | TNF, B3GAT3, ST3GAL3 | PTPN1 2783/4885F11 996/4885USP2 3573/4885 |
| US-11319338-B2 | Timosaponin compounds | APP, IAPP, BACE1 | PTPN1 3996/4885F11 1228/4885USP2 4673/4885 |
| US-20250333435-A1 | TIMOSAPONIN COMPOUNDS | APP, IAPP, BACE1 | PTPN1 3996/4885F11 1228/4885USP2 4673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.